We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Trigger Found for Inflammatory Response

By Biotechdaily staff writers
Posted on 05 Jul 2005
Researchers have found that the proteolytic enzyme cathepsin G, which is produced by the neutrophil class of immune cells, plays a critical role in the onset of inflammatory diseases such as arthritis.

Investigators at the Washington University School of Medicine (St. More...
Louis, MO, USA) created a model for arthritis by injecting laboratory mice with collagen from calf joints. They found that mice lacking cathepsin G did not develop an inflammatory response because the animals' neutrophils failed to initiate cytoskeletal reorganization and cell spreading. Addition of proteolytically active cathepsin G restored the neutrophils' ability to trigger inflammation, while inactive cathepsin G was unable to do so. These findings were published in the June 2005 issue of Immunity.

"The mice make antibodies to that protein because it is somewhat foreign, but the antibodies have enough cross-reactivity that they will bind to the mouse's own cartilage and collagen and initiate an inflammation,” explained senior author Dr. Christine Pham, assistant professor of medicine at Washington University. "This leads to a condition similar to rheumatoid arthritis in the mice. Cathepsin G affects a very early step in this kind of immune response, so inhibiting it has attractive potential for developers of therapeutics.”






Related Links:
Washington University School of Medicine

New
Gold Member
Automatic Hematology Analyzer
CF9600
New
Gold Member
Nucleic Acid Extractor System
NEOS-96 XT
New
Pipette Calibration System
Artel PCS®
New
Prefilled Tubes
Prefilled 5.0ml Tubes
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image

Urine-Based Multi-Cancer Screening Test Receives FDA Breakthrough Device Designation

Early detection across multiple cancers remains a major unmet need in population screening. Non-invasive approaches that can be delivered at scale may broaden access and shift diagnoses to earlier stages.... Read more

Molecular Diagnostics

view channel
Image: The new approach focuses on CpG DNA methylation, a chemical modification of cytosine and guanine bases, using tumor samples to develop a computational model that distinguishes among 21 cancer types (photo credet: 123RF)

Machine Learning Model Uses DNA Methylation to Predict Tumor Origin in Cancers of Unknown Primary

Cancers of unknown primary (CUP) are metastatic malignancies in which the primary site cannot be identified, complicating treatment selection. Many patients consequently receive broad, nonspecific chemotherapy... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.